The comparative activities of ampicillin, cefamandole, cefoxitin, cefaclor, and cefatrizine against both beta-lactamase-producing and non-beta-lactamase-producing isolates of Haemophilus influenzae were determined by using an agar dilution susceptibility test procedure. Ampicillin was the most active drug tested against non-beta-lactamase-producing isolates, whereas cefamandole was most active against beta-lactamase-producing strains.
The emergence of ampicillin-resistant (6, 11) and, now, chloramphenicol-resistant (7) strains of Haemophilus influenzae has prompted a search for alternative chemotherapeutic agents showing greater activity against these organisms. Certain of the newer cephalosporins, such as cefamandole, cefatrizine, and cefaclor, have shown greater activity against H. influenzae than did earlier cephalosporins such as cephalothin and cephalexin (4, 5, 12) . Cefoxitin, a member of the cephamycin class of antibiotics, has been shown to offer extreme resistance to degradation by gram-negative bacterial beta-lactamases (8, 12) .
The greater cerebrospinal fluid penetration of certain of the newer cephalosporins may allow their use for treatment of meningitis. However, there is also a need for effective chemotherapeutic agents against serious H. influenzae infections other than meningitis, for example, otitis media and acute epiglottitis (1, 9, 10) . Neither cephalothin nor cephalexin has been found previously to be effective in the treatment of these infections (12) .
The purpose of this study was to compare the in vitro activities of cefamandole, cefatrizine, cefaclor, cefoxitin, and ampicillin against 100 H. influenzae isolates, including 31 beta-lactamase producers. Most of the test strains were type b, although certain strains were non-typable. Susceptibility tests were performed by using an agar dilution technique with Mueller-Hinton agar and 5% supplement C (2). An inoculum of approximately 104 microorganisms was applied to the surface of the agar plates with a Steers-Foltz inoculum-replicating device. All susceptibility tests were incubated for 24 h at 35°C in a 3 to 5% C02 atmosphere. The miniimal inhibitory concentration (MIC) was defined as the lowest concentration of antibiotic that either prevented visible growth on the surface of the agar plates or allowed growth of no more than three colonies. Production of beta-lactamase by the test strains was determined by using a recently described rapid paper strip test (3) .
The results of testing 68 non-beta-lactamaseproducing isolates of H. influenzae are shown in (Fig. 2) , cefamandole was found to be the most active agent; 84% of strains were inhibited by 2 yg/ml, which is similar to data observed with the non-beta-lactamase-producing strains. Cefoxitin was only slightly more active than the two remaining cephalosporins; 82% of the strains were inhibited by 8 ,ug/ml of cefoxitin, and 98% were inhibited by 16 ,ug/ml. Cefaclor and cefatrizine again were quite similar in activity, with 85 to 90% of the isolates inhibited at 16 ,tg/ml. As expected, ampicillin was least active against these strains, with 32 ,ug/ml required to inhibit >90% of the test strains.
It was noted that all of the cephalosporin-type drugs except cefamandole were at least one twofold concentration increment less active against the beta-lactamase-producing strains than against the non-beta-lactamase group. One of the isolates included in this group was an ampicillin-resistant, but non-beta-lactamase-producing strain. The MIC of ampicillin for this strain was 8 ,ug/ml; the MIC of cefamandole was 64 ,ug/ml; that of cefoxitin was 128 ,tg/ml; that of cefaclor was >128 ,ug/ml; and that of cefatrizine was >64 ,ug/ml. The mechanism of resistance of this organism to beta-lactam drugs is unclear and bears further investigation.
In this study we compared the activities of several recently developed semisynthetic cephalosporin or cephamycin antibiotics against isolates of H. influenzae. These drugs showed superior inhibitory activities as compared with previous cephalosporins, especially against betalactamase-producing bacteria (4, 5, 12) . Two new oral cephalosporins, cefaclor and cefatrizine, also show good in vitro activity against beta-lactamase-producing H. influenzae. ACKNOWLEDGMENT This study was supported by a grant from Lilly Research Laboratories, Indianapolis, Ind.
